Private equity investment in Medicare Advantage has declined in recent years amid rising interest rates and an unfavorable regulatory environment, according to a report the Private Equity Stakeholder Project. These investor groups inked just four Medicare Advantage-related deals in 2023, the second-lowest total during the seven years the Private Equity Stakeholder Project has tracked such transactions. Over that period, private equity investments in Medicare Advantage insurers, brokerages and other companies peaked at 19 in 2021, then declined the next two years, according to the nonprofit organization, which focuses on transparency in private equity and supports laws to limit these firms’ activities.
Read the full article: Private Equity Medicare Advantage Investment Slumps: Report //
Source: https://www.modernhealthcare.com/finance/private-equity-medicare-advantage-pesp-report